Evidence map›Paper›PMID 16283258›Full record

Trial reportPsychopharmacology2006

Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy.

Saul Shiffman, Stuart G Ferguson, Chad J Gwaltney

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Nicotine replacement therapy versus control for smoking cessation.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Trial
  3. Impact of a Smoking Cessation Quitline in Vietnam: Evidence Base and Future Directions.International journal of environmental research and public health · 2019
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Effects of varenicline on abstinence and smoking reward following a programmed lapse.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. ASRS Questionnaire and Tobacco Use: Not Just a Cigarette. A Screening Study in an Italian Young Adult Sample.International journal of environmental research and public health · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saul ShiffmanUniversity of Pittsburgh and Pinney Associates, Pittsburgh, PA, USA. Shiffman@pinneyassociates.com
Stuart G Ferguson
Chad J Gwaltney

Funding

RELAPSE PROCESS IN TRANSDERMAL NICOTINE REPLACEMENTR01DA006084 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIFFMAN, SAUL · 1990 to 2001
$45k
NIDA NIH HHS DA 06084NIDA NIH HHS R01 DA006084
6 · The paper itself

Abstract

objective and rationaleSmoking lapses represent an important juncture between smoking cessation and relapse. Nicotine replacement therapy (NRT) has been shown to decrease the risk of progression from lapse to relapse. We hypothesized that this effect might be mediated via decreases in reinforcement from smoking lapses.

methodWe assessed 169 subjects who lapsed during treatment in a double-blind placebo-controlled study of high-dose (35 mg) nicotine patch. Following their first lapse, using an electronic diary, subjects recorded the amount they smoked, and rated the pleasantness and satisfaction ("hedonic rating") and the aversiveness of smoking. Subjects were then followed and assessed for further lapses and relapses.

resultsSubjects who smoked more during the first lapse had greater risk of progression [second lapse: hazard ratio (HR)=1.16, confidence interval (CI)=1.01-1.32; relapse: HR=1.22, CI=0.97-1.54]. Subjects with higher hedonic ratings of the first lapse also had a greater risk of progression to the second lapse (HR=1.08, CI=1.02-1.14) and to relapse (HR=1.26, CI=1.11-1.41). Aversive ratings had no bearing on progression. As expected, active treatment reduced the risk of both a second lapse (HR=0.54, CI=0.39-0.78) and a relapse (HR=0.22, CI=0.11-0.45). Importantly, however, NRT had no effect on hedonic ratings, amount smoked during the first lapse, or aversive ratings.

conclusionsHedonic response to an initial lapse predicted progression to relapse, but this did not mediate the effect of NRT on progression.

Indexed as

AttitudeReinforcement, PsychologySet, PsychologyAdministration, CutaneousAdultAffectBehavior TherapyDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansMaleMiddle AgedNicotineRisk AssessmentSecondary PreventionNicotine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.